Get facts, not fiction

Published 11 hours ago • loading... • Updated 6 hours ago

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

Summary by Globe Newswire

Psyence BioMed completes US$2.6M investment in PsyLabs following key regulatory and U.S. manufacturing milestones for its ibogaine program....

10 Articles

10 Articles

The Toronto Star

+9 Reposted by 9 other sources

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both milestones attached to its backstop subscription commitment in Psyence Labs Ltd. (“PsyLabs”) have been achieved and that the…

7 hours ago·Toronto, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources10

Leaning Left8Leaning Right1Center1Last Updated3 hours agoBias Distribution

80% Left

Bias Distribution

80% of the sources lean Left

80% Left

+3

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada 11 hours ago on Wednesday, October 21, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics